98%
921
2 minutes
20
Background: Reasons for first using cannabis (RFUC) may influence later use patterns and mental health outcomes. However, limited research has explored self-medication versus social RFUCs in depth, and their associations with cannabis use patterns and psychopathology in the general population.
Objectives: We examined RFUCs and their associations with (1) reasons for continuing cannabis use, (2) weekly THC (delta-9-tetrahydrocannabinol) unit consumption and (3) symptoms of paranoia, anxiety and depressive symptoms.
Methods: We analysed data from the Cannabis&Me (CAMe) population survey (March 2022-July 2024), including 2573 (75.9%) current and 816 (24.1%) past cannabis users aged 18 years or older.
Findings: Participants reported a mean weekly consumption of 206 THC units (SD=268). Initiating cannabis use for anxiety (β=36.22, p=3.3e-03), depression (β=40.37, p=1.74e-03) or because 'family members were using it' (β=87.43, p=1.22e-09) was associated with higher weekly THC units. RFUC to relieve physical discomfort (β=8.89, p=4.12e-07), pain (β=7.24, p=5.56e-06), anxiety (β=9.67, p=1.63e-16), depression (β=9.12, p=1.21e-13) and minor psychotic symptoms (β=16.46, p=1.2e-04) were linked to higher paranoia scores. Similar associations were observed for anxiety and depression. Conversely, starting for fun (β=-3.71, p=3.49e-05) or curiosity (β=-2.61, p=5e-03) was associated with lower paranoia and anxiety. RFUC for 'boredom' was linked to increased depression (β=1.09, p=3.8e-03).
Conclusions: Initiating cannabis use for self-medication is associated with higher average THC consumption, and increased anxiety, depression and paranoia.
Clinical Implications: Asking individuals why they first used cannabis may serve as a cost-effective screening tool to identify those who could benefit from monitoring, support, or referral to intervention services.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12382515 | PMC |
http://dx.doi.org/10.1136/bmjment-2025-301810 | DOI Listing |
Int J Drug Policy
September 2025
QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD 4006, Australia. Electronic address:
Background: Australia has one of the highest rates of cannabis use globally, yet the concentration of Δ9-tetrahydrocannabinol (THC) of illicit street cannabis has not been formally assessed in over a decade. We aimed to comprehensively profile the concentration of THC, cannabidiol (CBD) and other cannabinoids in contemporary illicit street cannabis in regional Australia, assess variation over time, and examine how the amount of THC relates to consumer's perceived product strength.
Methods: Participants donated two 1-gram samples of cannabis at 3 different timepoints (i.
BMJ Ment Health
August 2025
Social, Genetic, and Developmental Psychiatry Centre, King's College London Institute of Psychiatry Psychology and Neuroscience, London, UK.
Background: Reasons for first using cannabis (RFUC) may influence later use patterns and mental health outcomes. However, limited research has explored self-medication versus social RFUCs in depth, and their associations with cannabis use patterns and psychopathology in the general population.
Objectives: We examined RFUCs and their associations with (1) reasons for continuing cannabis use, (2) weekly THC (delta-9-tetrahydrocannabinol) unit consumption and (3) symptoms of paranoia, anxiety and depressive symptoms.
Psychol Med
August 2025
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Background: Childhood trauma is a well-established risk factor for psychosis, paranoia, and substance use, with cannabis being a modifiable environmental factor that exacerbates these vulnerabilities. This study examines the interplay between childhood trauma, cannabis use, and paranoia using standard tetrahydrocannabinol (THC) units as a comprehensive measure of cannabis exposure.
Methods: Data were derived from the Cannabis&Me study, an observational, cross-sectional, online survey of 4,736 participants.
Vet World
June 2025
Department of Fisheries, Faculty of Fisheries and Marine Science, University of Jenderal Soedirman, Purwokerto, Indonesia.
Background And Aim: Infectious myonecrosis virus (IMNV) is a significant pathogen affecting , causing high mortality and substantial economic losses in shrimp aquaculture. Conventional chemotherapeutics have limited efficacy and raise environmental concerns. This study explores the immunostimulatory potential of squid ( spp.
View Article and Find Full Text PDFInt J Drug Policy
September 2025
Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, United Kingdom.